Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)

Rodrigo Fonseca; Mariano Arribas; Julia E. Wiedmeier-Nutor; Yael N. Kusne; Miguel González Vélez; Heidi E. Kosiorek; Richard (Duke) J. Butterfield; Ilan R. Kirsch; Joseph R. Mikhael; A. Keith Stewart; Craig Reeder; Jeremy Larsen; P. Leif Bergsagel; Rafael Fonseca

doi:10.1038/s41408-023-00856-0

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)

Rodrigo Fonseca, Mariano Arribas, Julia E. Wiedmeier-Nutor, Yael N. Kusne, Miguel González Vélez, Heidi E. Kosiorek, Richard (Duke) J. Butterfield, Ilan R. Kirsch, Joseph R. Mikhael, A. Keith Stewart, Craig Reeder, Jeremy Larsen, P. Leif Bergsagel, Rafael Fonseca

Hematology/Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Blood Cancer Journal, published online 06 March 2023 Following the publication of this article the authors noted and error in Figure 4, “Kaplan Meier curves for time to next treatment (TTNT) according to sequential MRD measurements”. The figure should have displayed only patients who had MRD taken at least 1 year apart (as defined by IMWG), but instead it incorrectly included an additional 8 patients with sequential measurements taken only at least 6 months apart. The correct figure shows results based on the first MRD taken at least 1 year apart following day 100 evaluation, and should have appeared as below: (Figure presented.) The original article has been corrected.

Original language	English (US)
Article number	87
Journal	Blood cancer journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41408-023-00856-0
State	Published - Dec 2023

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-023-00856-0

Fingerprint

Dive into the research topics of 'Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)'. Together they form a unique fingerprint.

Cite this

Fonseca, R., Arribas, M., Wiedmeier-Nutor, J. E., Kusne, Y. N., González Vélez, M., Kosiorek, H. E., Butterfield, R. J., Kirsch, I. R., Mikhael, J. R., Stewart, A. K., Reeder, C., Larsen, J., Bergsagel, P. L., & Fonseca, R. (2023). Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x). Blood cancer journal, 13(1), Article 87. https://doi.org/10.1038/s41408-023-00856-0

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x). / Fonseca, Rodrigo; Arribas, Mariano; Wiedmeier-Nutor, Julia E. et al.
In: Blood cancer journal, Vol. 13, No. 1, 87, 12.2023.

Research output: Contribution to journal › Comment/debate › peer-review

Fonseca, R, Arribas, M, Wiedmeier-Nutor, JE, Kusne, YN, González Vélez, M, Kosiorek, HE, Butterfield, RJ, Kirsch, IR, Mikhael, JR, Stewart, AK, Reeder, C, Larsen, J, Bergsagel, PL & Fonseca, R 2023, 'Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)', Blood cancer journal, vol. 13, no. 1, 87. https://doi.org/10.1038/s41408-023-00856-0

Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, González Vélez M, Kosiorek HE et al. Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x). Blood cancer journal. 2023 Dec;13(1):87. doi: 10.1038/s41408-023-00856-0

@article{bfc888eac965426ba700c6d3e612870b,

title = "Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)",

abstract = "Correction to: Blood Cancer Journal, published online 06 March 2023 Following the publication of this article the authors noted and error in Figure 4, “Kaplan Meier curves for time to next treatment (TTNT) according to sequential MRD measurements”. The figure should have displayed only patients who had MRD taken at least 1 year apart (as defined by IMWG), but instead it incorrectly included an additional 8 patients with sequential measurements taken only at least 6 months apart. The correct figure shows results based on the first MRD taken at least 1 year apart following day 100 evaluation, and should have appeared as below: (Figure presented.) The original article has been corrected.",

author = "Rodrigo Fonseca and Mariano Arribas and Wiedmeier-Nutor, {Julia E.} and Kusne, {Yael N.} and {Gonz{\'a}lez V{\'e}lez}, Miguel and Kosiorek, {Heidi E.} and Butterfield, {Richard (Duke) J.} and Kirsch, {Ilan R.} and Mikhael, {Joseph R.} and Stewart, {A. Keith} and Craig Reeder and Jeremy Larsen and Bergsagel, {P. Leif} and Rafael Fonseca",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1038/s41408-023-00856-0",

language = "English (US)",

volume = "13",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)

AU - Fonseca, Rodrigo

AU - Arribas, Mariano

AU - Wiedmeier-Nutor, Julia E.

AU - Kusne, Yael N.

AU - González Vélez, Miguel

AU - Kosiorek, Heidi E.

AU - Butterfield, Richard (Duke) J.

AU - Kirsch, Ilan R.

AU - Mikhael, Joseph R.

AU - Stewart, A. Keith

AU - Reeder, Craig

AU - Larsen, Jeremy

AU - Bergsagel, P. Leif

AU - Fonseca, Rafael

PY - 2023/12

Y1 - 2023/12

N2 - Correction to: Blood Cancer Journal, published online 06 March 2023 Following the publication of this article the authors noted and error in Figure 4, “Kaplan Meier curves for time to next treatment (TTNT) according to sequential MRD measurements”. The figure should have displayed only patients who had MRD taken at least 1 year apart (as defined by IMWG), but instead it incorrectly included an additional 8 patients with sequential measurements taken only at least 6 months apart. The correct figure shows results based on the first MRD taken at least 1 year apart following day 100 evaluation, and should have appeared as below: (Figure presented.) The original article has been corrected.

AB - Correction to: Blood Cancer Journal, published online 06 March 2023 Following the publication of this article the authors noted and error in Figure 4, “Kaplan Meier curves for time to next treatment (TTNT) according to sequential MRD measurements”. The figure should have displayed only patients who had MRD taken at least 1 year apart (as defined by IMWG), but instead it incorrectly included an additional 8 patients with sequential measurements taken only at least 6 months apart. The correct figure shows results based on the first MRD taken at least 1 year apart following day 100 evaluation, and should have appeared as below: (Figure presented.) The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85160213121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160213121&partnerID=8YFLogxK

U2 - 10.1038/s41408-023-00856-0

DO - 10.1038/s41408-023-00856-0

M3 - Comment/debate

C2 - 37230980

AN - SCOPUS:85160213121

SN - 2044-5385

VL - 13

JO - Blood cancer journal

JF - Blood cancer journal

IS - 1

M1 - 87

ER -

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Blood Cancer Journal, (2023), 13, 1, (32), 10.1038/s41408-023-00794-x)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this